Cambridge Antibody Technology
| Use attributes for filter ! | |
| Founded | 1989 |
|---|---|
| Successor | MedImmune |
| Revenue | 172. 5 million GBP (six months ending 31 March 2006*) |
| Headquarters | Cambridgeshire |
| United Kingdom | |
| Founders | Medical Research Council |
| Gregory Winter | |
| David Chiswell | |
| Type of business | Public limited company |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1243311 |
About Cambridge Antibody Technology
Cambridge Antibody Technology was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.
